Core Outcome Domains for Clinical Trials on Somatic Symptom Disorder, Bodily Distress Disorder, and Functional Somatic Syndromes: European Network on Somatic Symptom Disorders Recommendations.

Psychosom Med

From the Department of Psychology (Rief), Philipps University, Marburg, Germany; University of Aberdeen (Burton), Aberdeen, UK; University of Aarhus (Frostholm, Schröder), Aarhus, Denmark; Technical University of Munich (Henningsen), München, Germany; University of Marburg (Kleinstäuber), Marburg, Germany; Tilburg University (Kop, van der Feltz-Cornelis), Tilburg, the Netherlands; University Medical Center, Hamburg-Eppendorf (Löwe, Shedden-Mora, Toussaint), Hamburg, Germany; University of Wuppertal (Martin), Wuppertal, Germany; University of Oslo (Malt), Oslo, Norway; and University of Groningen (Rosmalen), Groningen, the Netherlands.

Published: June 2018

Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and pooling of data, and simplifies the preparation and review of research projects and comparison of risks and benefits of treatments. Therefore, we provide recommendations for the core outcome domains that should be considered in clinical trials on the efficacy and effectiveness of interventions for somatic symptom disorder, bodily distress disorder, and functional somatic syndromes.

Methods: The European Network on Somatic Symptom Disorders group of more than 20 experts in the field met twice in Hamburg to discuss issues of assessment and intervention research in somatic symptom disorder, bodily distress disorder, and functional somatic syndromes. The consensus meetings identified core outcome domains that should be considered in clinical trials evaluating treatments for somatic symptom disorder and associated functional somatic syndromes.

Results: The following core domains should be considered when defining ascertainment methods in clinical trials: a) classification of somatic symptom disorder/bodily distress disorder, associated functional somatic syndromes, and comorbid mental disorders (using structured clinical interviews), duration of symptoms, medical morbidity, and prior treatments; b) location, intensity, and interference of somatic symptoms; c) associated psychobehavioral features and biological markers; d) illness consequences (quality of life, disability, health care utilization, health care costs; e) global improvement and treatment satisfaction; and f) unwanted negative effects.

Conclusions: The proposed criteria are intended to improve synergies of clinical trials and to facilitate decision making when comparing different treatment approaches. These recommendations should not result in inflexible guidelines, but increase consistency across investigations in this field.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PSY.0000000000000502DOI Listing

Publication Analysis

Top Keywords

somatic symptom
28
clinical trials
24
functional somatic
20
core outcome
16
outcome domains
16
symptom disorder
16
distress disorder
16
somatic
13
disorder bodily
12
bodily distress
12

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!